[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

WO2008145850A3 - Use of an active ingredient derived from amaranth (amaranthus hypochondriacus) for preparing a composition for protecting mitochondria - Google Patents

Use of an active ingredient derived from amaranth (amaranthus hypochondriacus) for preparing a composition for protecting mitochondria Download PDF

Info

Publication number
WO2008145850A3
WO2008145850A3 PCT/FR2008/000573 FR2008000573W WO2008145850A3 WO 2008145850 A3 WO2008145850 A3 WO 2008145850A3 FR 2008000573 W FR2008000573 W FR 2008000573W WO 2008145850 A3 WO2008145850 A3 WO 2008145850A3
Authority
WO
WIPO (PCT)
Prior art keywords
active ingredient
amaranth
composition
preparing
protecting
Prior art date
Application number
PCT/FR2008/000573
Other languages
French (fr)
Other versions
WO2008145850A2 (en
Inventor
Farra Claude Dal
Nouha Domloge
Jean-Marie Botto
Original Assignee
Soc Extraction Principes Actif
Farra Claude Dal
Nouha Domloge
Jean-Marie Botto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Soc Extraction Principes Actif, Farra Claude Dal, Nouha Domloge, Jean-Marie Botto filed Critical Soc Extraction Principes Actif
Publication of WO2008145850A2 publication Critical patent/WO2008145850A2/en
Publication of WO2008145850A3 publication Critical patent/WO2008145850A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/011—Hydrolysed proteins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Dermatology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medical Informatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Birds (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention relates to the use, in a cosmetic composition or for preparing a pharmaceutical composition, of an effective amount of an active ingredient derived from amaranth; wherein the active ingredient, or the composition containing the latter, is for protecting the mitochondria and for activating aconitase. The active ingredient comes from the hydrolysis of amaranth (Amaranthus hypochondriacus) proteins and contains mainly polypeptides and peptides. It may be used alone or in combination with at least one other active ingredient. The invention also relates to a cosmetic treatment process for protecting the skin and the appendages against external attacks and for combating skin ageing.
PCT/FR2008/000573 2007-04-27 2008-04-23 Use of an active ingredient derived from amaranth (amaranthus hypochondriacus) for preparing a composition for protecting mitochondria WO2008145850A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0703048A FR2915377B1 (en) 2007-04-27 2007-04-27 USE OF AN ACTIVE INGREDIENT FROM AMARANTE (AMARANTHUS) FOR PREPARING A COMPOSITION INTENDED TO PROTECT MITOCHONDRIA
FR0703048 2007-04-27

Publications (2)

Publication Number Publication Date
WO2008145850A2 WO2008145850A2 (en) 2008-12-04
WO2008145850A3 true WO2008145850A3 (en) 2009-02-05

Family

ID=39000677

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2008/000573 WO2008145850A2 (en) 2007-04-27 2008-04-23 Use of an active ingredient derived from amaranth (amaranthus hypochondriacus) for preparing a composition for protecting mitochondria

Country Status (2)

Country Link
FR (1) FR2915377B1 (en)
WO (1) WO2008145850A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2938766B1 (en) * 2008-11-26 2010-12-31 Isp Investments Inc COSMETIC AND / OR PHARMACEUTICAL COMPOSITION COMPRISING VINE LEAF HYDROLYSAT (VITIS VINIFERA L.) AS ACONITASE ACTIVATOR ACTIVE INGREDIENT AND MITOCHONDRIA PROTECTOR
FR2943542B1 (en) * 2009-03-31 2012-05-25 Lvmh Rech METHOD OF ANTI-AGE COSMETIC CARE BY STIMULATING THE ACTIVITY OF MITOCHONDRIAL ACONISATE
RU2759806C1 (en) * 2021-03-26 2021-11-18 Гордейчук Владимир Евгеньевич Method for reducing the expression levels of lrnn3, grap, vamp 5 genes

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2266750C2 (en) * 2003-07-31 2005-12-27 Одинец Алексей Глебович Method for preparing biologically active peptide-enriched serum
US20060141063A1 (en) * 2004-12-28 2006-06-29 Council Of Scientific & Industrial Research Health promoting functional foods fortified with herbs

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2266750C2 (en) * 2003-07-31 2005-12-27 Одинец Алексей Глебович Method for preparing biologically active peptide-enriched serum
US20060141063A1 (en) * 2004-12-28 2006-06-29 Council Of Scientific & Industrial Research Health promoting functional foods fortified with herbs

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Week 200631, Derwent World Patents Index; AN 2006-297748, XP002467541 *
WILLIAM E. WALDEN, ANNA I. SELEZNEVA, JÉRÔME DUPUY, ANNE VOLBEDA, JUAN C. FONTECILLA-CAMPS, ELIZABETH C. THEIL, KARL VOLZ: "Structure of Dual Function Iron Regulatory Protein 1 Complexed with Ferritin IRE-RNA", SCIENCE, vol. 314, 22 December 2006 (2006-12-22), Washington DC, pages 1903 - 1908, XP002468769, Retrieved from the Internet <URL:www.sciencemag.org> [retrieved on 20080212] *

Also Published As

Publication number Publication date
WO2008145850A2 (en) 2008-12-04
FR2915377A1 (en) 2008-10-31
FR2915377B1 (en) 2009-08-21

Similar Documents

Publication Publication Date Title
JP2006117700A5 (en)
PL1962815T3 (en) Use of film-forming hair-care polymers from the group of polyurethanes and pharmaceutical preparations and plasters containing said polymers
WO2009101503A3 (en) Use of natural active substances in cosmetic or therapeutic compositions
WO2009074735A8 (en) Use of a novel natural agent in cosmetic compositions
WO2009043991A3 (en) Use of an active principle from flax for use in a composition for activating cytochrome c
WO2006136607A3 (en) Use of hydrophobin-polypeptides and conjugates from hydrophobin-polypeptides having active and effect agents and the production thereof and use thereof in the cosmetic industry
WO2008043944A3 (en) Use of an active ingredient derived from flax that acts on the papillary dermis, for its anti-ageing action
WO2009044279A3 (en) Peptides having antimicrobial and/or biosurfactant properties
WO2008118017A3 (en) Prame derived peptides and immunogenic compositions comprising these
WO2008128775A3 (en) Stabilised pharmaceutical composition containing pregabaline
RS53056B (en) Pharmaceutical composition comprising (1s)-1,5-anhydro-1-[5-(4-ethoxybenzyl)-2-metoxy-4-methylphenyl]-1-thio-d-glucitol and metformin and uses thereof in the treatment of diabetes
WO2010030180A3 (en) Peptide formulations and uses thereof
WO2010020424A3 (en) Use of glucosylglycerol
WO2008145849A3 (en) Pharmaceutical and/or cosmetic composition containing aconitase-activating active ingredients
WO2012161497A3 (en) Peptide derivatives having a superior moisturizing effect and uses thereof
WO2007096859A3 (en) Protection of the retina against laser injury by adnf peptides such as nap and sal
WO2008145850A3 (en) Use of an active ingredient derived from amaranth (amaranthus hypochondriacus) for preparing a composition for protecting mitochondria
WO2012173458A3 (en) Stabilized active materials contained in plant cells and method for preparing same
WO2007100874A3 (en) Compositions containing peptides with non-natural amino acids and methods of use
WO2010117709A3 (en) Peptide-based systems for delivery of costmetic agents
WO2008145853A3 (en) Use of an active ingredient derived from amaranth (amaranthus) for preparing a composition for activating cell energy and for protecting the skin against oxidative damage
WO2018094023A3 (en) Cyclic dipeptides and wound healing
WO2008145855A8 (en) Pharmaceutical and/or cosmetic composition containing a cytochrome c-activating active ingredient
WO2008050157A3 (en) Ozonated oil formulations
WO2008145848A3 (en) Pharmaceutical and/or cosmetic composition containing peptides

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08805492

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08805492

Country of ref document: EP

Kind code of ref document: A2